🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MPS (RaDiCo Cohort) (RaDiCo-MPS)

Recruitingn/aAges any - anyAllInstitut National de la Santé Et de la Recherche …
NCT06036693 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Confirmed diagnosis of MPS based on clinically relevant enzyme deficiency, with abnormally elevated GAG urinary excretion and/or identification of pathogenic mutations. * Signed informed consent or parents/guardian non-opposition for deceased patients (minor or protected major) There are no non-inclusion criteria.
💊

What it tests

  • Not listed
📍

Where

23 sites
Centre Hospitalier Universitaire d'Angers
Angers, France
Hôpital des Enfants - Groupe Hospitalier Pellegrin
Bordeaux, France
Hôpital Morvan
Brest, France
Hôpital d'Estaing
Clermont-Ferrand, France
Hôpital Beaujon
Clichy, France
Hôpital Raymond-Poincaré
Garches, France
Hôpital Jeanne de Flandre
Lille, France
Hôpital de la Timone
Marseille, France

…and 15 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy